This week, Marianna sits down with Carolyn Chu and Astha Kanani from the National Clinician Consultation Center (NCCC) to talk about treatment interruptions when it comes to HIV and Hepatitis C or HCV. Learn about why this can happen, the impact on treatment outcomes, and what you as an HIV care provider can do to prevent them.
--
Reach out to the NCCC at 844-ASK-NCCC or 844-275-6222.
Learn more at nccc.ucsf.edu.
Resources mentioned in this episode:
Dannenberg C, Matthews H, Hüfner A, et al. Long-term real-world use of cabotegravir/rilpivirine: adherence and virological efficacy over a 44-month observation period. Infect Dis Ther. 2025:14(8):1775-1797.
De La Hoz A, Pooja A, Kancharla A, et al. Characteristics and outcomes of direct-acting antiviral experienced patients with hepatitis C undergoing retreatment at an essential hospital in the United States. Open Forum Infect Dis. 2024;11(12):ofae704.
--
Help us track the number of listeners our episode gets by filling out this brief form! (https://www.e2NECA.org/?r=AQX7941)
--
Want to chat? Email us at [email protected] with comments or ideas for new episodes.
--
Check out our free online courses: www.necaaetc.org/rise-courses
--
Download our HIV mobile apps:
Google Play Store: https://play.google.com/store/apps/developer?id=John+Faragon&hl=en_US&gl=US
Apple App Store: https://apps.apple.com/us/developer/virologyed-consultants-llc/id1216837691